Our Pipeline

We have built a deep pipeline of multi-specific biotherapeutic antibodies with the intent of bringing safe, efficacious medicines to patients in need. We are advancing our pipeline both independently and with a number of corporate, clinical and academic partners. Because we have designed our product candidates to have a highly favorable benefit-to-risk profile, we enable different combination therapies and approaches.